Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Johnson & Johnson Raised Its Dividend Every Year. Why Did It Trail the S&P 500?
Johnson & Johnson (JNJ) Drugs Lift Guidance, but Is 23 Times Earnings Fair?
Top Pharmaceutical Stocks Worth Watching - October 21st - Zolmax
Treasury Yields Are Near 5%. Should Retirees Rethink Dividend Stocks?
Johnson & Johnson's Profit Fell 96% Year-Over-Year. But the Dividend Has Risen for 64 Years in a Row
Washburn Capital Management Inc. Makes New Investment in Johnson & Johnson $JNJ
Global Life Science Market Report 2026: Size, Trends and Forecast to 2030 | Secure $200.6B AI and Precision Medicine Upside with Johnson & Johnson, Roche, Pfizer, and AstraZeneca
13,337 Shares in Johnson & Johnson $JNJ Purchased by Greg Jennings LLC
Johnson & Johnson (NYSE:JNJ) Stock Rating Cut to Hold at Erste Group Bank - Daily Political
Johnson & Johnson (NYSE:JNJ) Shares Climb 2.2% - Here's What Happened
2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going)
Dow leads Wall Street higher, investors focus on healthcare stocks
Lawsuit accuses Essity, Edgewell, J&J of violating PFAS ban in California
Healthcare Stocks To Research - October 20th - Markets Daily
Johnson & Johnson (JNJ): Are Its Medical Device Deals Paying Off?
J&J Launches Faster Coronary IVL Catheter, Highlights Abu Dhabi Surgical Collaboration
Johnson & Johnson (NYSE:JNJ) Stock Jumps 2.2% - Still a Buy? - Daily Political
What Capital Group Core Balanced ETF (CGBL) Bought: JNJ Leads on Oct. 16
Pharmaceutical Stocks To Consider - October 20th - Daily Political
Multiple Myeloma Pipeline 2026: Who Is Leading the Race? Top Companies and Emerging Therapies to Watch by DelveInsight | Bluebird bio, Cellectis SA, Caribou Biosciences, Luminary Therapeutics | ABNewswire
Best Pharmaceutical Stocks To Keep An Eye On - October 19th - Markets Daily
Johnson & Johnson's Dividend Machine Is Running. Can Earnings Keep Up?
Johnson & Johnson Reports 48-Week Tremfya Results in Phase 3 Crohn's Disease Fistula Study
Ds vs. Dividend Stocks: One Protects Your Principal, the Other Could Grow Your Income
Is Johnson & Johnson (JNJ) Undervalued Following Its Latest Oncology Update?
Johnson & Johnson announces new data showing TREMFYA® (guselkumab) is the only IL-23 to deliver durable fistula remission through 48 weeks in Crohn's disease with perianal fistula | Morningstar
Johnson & Johnson Stock Could Be a Defensive Play for the Years Ahead
Johnson & Johnson $JNJ Stock Sold by PineStone Asset Management Inc.
Johnson & Johnson $JNJ Stock: 1834 Investment Advisors Co. Reduces Holdings
What Does Johnson & Johnson (JNJ) News Mean For Its Growth Case? - Simply Wall St News
Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel Coats | Valuespectrum.com
Best Healthcare Stocks To Keep An Eye On - October 18th - Stock Observer
Healthcare Stocks To Consider - October 15th - Markets Daily
Johnson & Johnson $JNJ Stock: Goelzer Investment Management Inc. Decreases Holdings
Johnson & Johnson $JNJ Stock: Cyndeo Wealth Partners LLC Lowers Position
Johnson & Johnson $JNJ Position Lessened by Banque Pictet & Cie SA
Johnson & Johnson (NYSE:JNJ) Stock Gets Price Target Reduction from Morgan Stanley - Zolmax
JNJ Investors with $100,000 in Losses Have Opportunity to Join Johnson & Johnson Fraud Investigation with SBS Law | Morningstar
Healthcare Stocks To Consider - October 17th - Markets Daily
Johnson & Johnson $JNJ Stock Sold by First Merchants Corp - Markets Daily
Johnson & Johnson $JNJ Stock: Guyasuta Investment Advisors Inc. Decreases Stake - Markets Daily
Community Financial Services Group LLC Buys 3,745 Shares of Johnson & Johnson $JNJ - Stock Observer
Johnson & Johnson Just Raised Its Sales Outlook Again. Here's Why the Dividend King Is Still a Buy. - AOL
Johnson & Johnson $JNJ Position Boosted by Assenagon Asset Management S.A.
Former J&J site cleared for £31m redevelopment
Targeted oral peptides could reshape how precision prescription medicines reach patients
Healthcare Stocks To Add to Your Watchlist - October 16th - Stock Observer
J&J Says CHMP Recommends Approval Of TALVEY Combo In Earlier Line Treatment Of R/R Multiple Myeloma
Does Raised 2026 Outlook Change The Bull Case For Johnson & Johnson (JNJ)?
Johnson & Johnson $JNJ Stock Sold by Ninety One UK Ltd
Johnson & Johnson $JNJ Stock Sold by Fort Washington Investment Advisors Inc. OH - Zolmax
Fort Washington Investment Advisors Inc. OH Sells 539,918 Shares of Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Stock: ZWJ Investment Counsel Inc. Boosts Holdings - Daily Political
Johnson & Johnson $JNJ Stock Sold by Curated Wealth Partners LLC - Stock Observer
Johnson & Johnson $JNJ Stock Sold by State of Alaska Department of Revenue - Daily Political
Johnson & Johnson $JNJ Shares Sold by Ninety One North America Inc. - Daily Political
3 Companies Raising Guidance This Earnings Season
Here's our monthly update on our 32 stocks, including 2 more names to buy
Procter & Gamble Has Raised Its Dividend for 70 Years. These 4 Stocks Also Reward Patience
Pharmaceutical Stocks To Keep An Eye On - October 15th - Zolmax
Leaning Into Energy Stocks as Midterm Elections Draw Near
Johnson & Johnson and Protagonist Therapeutics Icotyde: The Best Inventions of 2026
Healthcare Stocks To Consider - October 15th - Daily Political
Morgan Stanley Has Lowered Expectations for Johnson & Johnson (NYSE:JNJ) Stock Price - Daily Political
Johnson & Johnson (JNJ) To Go Ex-Dividend on November 24th - Stock Observer
Johnson & Johnson $JNJ Stock Bought by Sanders Morris Harris LLC
Johnson & Johnson $JNJ Stock Purchased by Columbus Macro LLC
Johnson & Johnson $JNJ Stock: Cliftonlarsonallen Wealth Advisors LLC Boosts Position
FY2026 EPS Estimate for Johnson & Johnson Lowered by Analyst - Markets Daily
Johnson & Johnson $JNJ Stock Bought by Mather Group LLC. - Daily Political
4,087 Johnson & Johnson $JNJ Shares Bought by First Pacific Financial - Daily Political
33,173 Capital Group Core Balanced ETF $CGBL Shares Bought by Johnson Bixby & Associates LLC - Daily Political
Combination therapy for BCG-unresponsive non-muscle-invasive bladder cancer: biological rationale and ongoing clinical strategies
JNJ Maintains Rating by Leerink Partners -- Price Target Lowered
Johnson & Johnson $JNJ Stock: Thurston Springer Miller Herd & Titak Inc. Lowers Position
Johnson & Johnson $JNJ Stock Sold by Generate Investment Management Ltd
Johnson & Johnson $JNJ Holdings Trimmed by Generate Investment Management Ltd
Royal Bank Of Canada Issues Pessimistic Forecast for Johnson & Johnson (NYSE:JNJ) Stock Price
Top Healthcare Stocks To Research - October 14th - Stock Observer
Johnson & Johnson $JNJ Stake Lifted by First Citizens Bank & Trust Co. - Zolmax
Johnson & Johnson (JNJ) Stock Dropped, What Is Behind The Latest Attention? - Simply Wall St News
22,136 Johnson & Johnson $JNJ Shares Acquired by First Citizens Bank & Trust Co.
Blockbuster Drugs Come and Go. These 5 Pharma Dividend Stocks Keep Paying
Will New Business Development VP Hire and Lens Expansion Strategy Change STAAR Surgical's (STAA) Narrative
Comparing Fortress Biotech (NASDAQ:FBIO) and Johnson & Johnson (NYSE:JNJ) - Stock Observer
5,122 Johnson & Johnson $JNJ Shares Sold by Perpetual Ltd
Promising Pharmaceutical Stocks To Follow Now - October 11th - Markets Daily
Johnson & Johnson stock rout: What's driving the sharp decline?
Promising Healthcare Stocks To Keep An Eye On - October 11th - Stock Observer
Johnson & Johnson Reports Strong Q3 Earnings Amidst Middle East Conflict Impacting Medical Device Sales, ETPharma
Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial
Johnson & Johnson (NYSE:JNJ) Releases FY 2026 Earnings Guidance
JnJ News
CoreWeave Stock Forecast 2026–2030: Can CRWV Recover From the AI Debt Sell-Off?
Nebius Stock Price Prediction 2026–2030: Can AI Cloud Growth Justify the Cost?
Eli Lilly Stock Forecast 2026–2030: Can LLY Break Above $1,300 After Its 7% Five-Session Rally?
Is Tesla Stock a Good Buy Right Now? Earnings, AI Growth and Valuation Risks
Latest news
Show more
Super Micro Stock Jumps 9.6% as Strong AI Server Update Lifts Dell and HPE
Meta Stock Rises as Record $64.6 Billion Revenue Outweighs Surging AI Spending
Oil Price Today Rises Above $110 as Middle East Conflict Revives Supply Fears
EUR/USD Edges Higher Near 1.1240 as French Debt Concerns Limit Recovery
USD/JPY Holds Near 158 as Japan’s Trade Deficit Widens and Rate Uncertainty Persists
Netflix Stock Falls Nearly 6% After Hours as Weak Outlook Overshadows Earnings Beat
